DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20173134

To study doctor’s beliefs, barriers, awareness, and actual practices regarding use of generic medicines

Venkatesh V. Khadke, Shahbaz Yasin Khanda

Abstract


Background: Government of India is trying to popularize generic medicines, still most Registered Medical Practitioners (RMPs) doubt its quality and efficacy. We conducted a cross sectional survey to study the barriers that hinders the practice of writing generic prescriptions. The aim was to study doctor’s knowledge, beliefs and actual practices regarding generic medicines. This study is a KAP survey model (Knowledge, attitude, practices) to study beliefs, barriers, awareness and actual practices regarding use of generic medicines amongst private practioners and RMPs of tertiary care Government hospital in Nanded city.

Methods: A cross sectional survey was conducted on a sample of 300 randomly selected RMPs practicing in Nanded, Maharashtra. A 26-item questionnaire was designed, validated, and data collected through personal visits. Fisher’s exact test was applied to see associations between variables using Graphpad Prism 7.

Results: 234 RMPs responded to the questionnaire i.e. a response rate of 78% was achieved. 107 (45.7%) participants claimed to be actively prescribing generic medicines. 122 (52.1%) of the participants were unaware of any generic medical shop in their locality. 83 (35.5%) participants believed generics to be duplicate/ substandard. However, 16 (19.3%) of them still prescribed generics. One-third of them actually preferred its use for family.

Conclusions: RMPs do not accept the use of generic medicines for concerns about its quality and efficacy. Also, there was unawareness regarding availability of generic medicines in the locality. RMPs need to be educated about manufacture, sale and quality aspects of generic medicines in India.


Keywords


Awareness, Barriers, Beliefs, Generic medicines, Practices, RMPs

Full Text:

PDF

References


Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373:240-49.

Saksena P, Xu K, Elovainio R, Perrot J. Health services utilization and out-of-pocket expenditure at public and private facilities in low income countries. World Health report, Background paper, 20; 2010.

Alam M, Tyagi RP. A Study of Out of Pocket Household Expenditure on Drugs and Medical Services-An Exploratory Analysis of UP, Rajasthan and Delhi. Population Research Centre, Institute of Economic Growth; Oct 2009.

Nightingale SL. From the food and drug administration. JAMA. 1998 Mar 4;279(9):645. (PMID: 9496968).

Singhal GL, Kotwani A, Nanda A. Jan aushadhi stores in India and quality of medicines therein. Int J Pharmacy Pharm Sci. 2011;3(1):204-7.

Singal GL, Nanda A. Generics Drugs in India– Whether an Affordable Alternative to Branded Drugs: A Critical Study. The Pharma Review. 2008 Jun;6(34):637‐42.

Wazana A. Prescribers and the Pharmaceutical Industry: Is a gift ever just a gift? JAMA. 2000 Jan 19;283(3):373‐80.

Fischer MA, Keough ME, Baril JL, Saccoccio L, Mazor KM, Ladd E. Prescribers and pharmaceutical representatives: Why are we still meeting? J Gen Intern Med. 2009 Jul; PMC2695530.

de Vries TPGM, Henning RH, Hogerzeil HV, Fresle DA. Guide to Good Prescribing- A Practical Manual. World Health Organisation, Action Programme on Essential Drugs, Geneva. WHO/DAP/94.11

Clarke T, Berkrot B. Unease grows among U.S. doctors over Indian drug quality. Reuters. 2014. Available from: in.reuters.com/article/idINDEEA2H03120140318?irpc=932

Jha DN. No quality control for life saving generic drugs, govt. apathetic. The Times of India; 2014. Available from: timesofindia.com/india/No-quality-control-for-life-saving-generic-drugs-govt-apathetic/articleshow/42586381.cms

Mathur A, Bate R, Jin GZ. India must fix its Drug Quality Problem. The Forbes; 2014. Available from: www.forbes.com/sites/thyeapothecary/2014/09/17/india-must-fix-its-drug-quality-problem/#727a78a5563611530bd35636

U.S. Food and Drug Administration. Department of Health and Human Services. Available from: http://www.fda.gov.in

Verma S, Kumar R, Philip PJ. The Business of Counterfeit Drugs in India: A Critical Evaluation, Int J of Man and Int Bus Stu. 2014;4(2):141-8.

Report on Country wide Survey for spurious drugs. 2009. Central Drugs Standard Control Organisation, Directorate General of Health services, Ministry of Health and family Welfare, Government of India.

Chandran S, Roy A, Jain L. Implications of New Patent Regime on Indian Pharmaceutical Industry: Challenges and Opportunities. Journal of Intellectual Property Rights. 2005;10:269-80.

Jan A. Bureau of Pharma PSUs of India, Dept. Of Pharmaceuticals, Government of India. janaushadhi.gov.in/about_jan_aushadhi.html

Chua GN, Hassali MA, Shafie AA, Awaisu A. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia. Health Policy-MAY 2010.

Ahire K, Shukla M, Gattani M, Singh V, Singh M. A Survey Based Study in Current Scenario of Generic and Branded Medicines. International Journal of pharmacy and pharmaceutical sciences. 2013;5(3):705-11.

Kellerman SE. Physicians Response to Surveys: A Review of the Literature. Am J Prev Med. 2001;20(1):61-7.

Jamshed SQ, Ibrahim MIM, Hassali MA, Masood I, Low BY, Shafie AA, et al. Perception and attitude of general practitioners regarding generic medicines in Karachi, Pakistan: A questionnaire based study. Southern Med Review. 2012;1:22-30.

Hassali MA, Kong DCM, Stewart K. Generic medicines: Perceptions of general practitioners in Melbourne, Australia. Journal of Generic medicine. 2006;3(3):214-25.

Salhia HO, Ali A, Rezk NL, El Metwally A. Perception and attitude of physicians toward local generic medicines in Saudi Arabia: A questionnaire-based study. Saudi Pharm J. 2015 Sep;23(4):397-404.

Joseph OF, Adekunle OA, Olufemi OD, Okezie OE, Aliyu MM, Olayinka O et al. The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians. Expert Rev Pharmacoecon Outcomes Res. 2015 Dec 28:1-12.

Hassali MA, Wong ZY, Alian AA, Saleem F, Yahaya AHM, Hisham A. Does educational intervention improve doctors’ knowledge and perceptions of generic medicines and their generic prescribing rate? A study from Malaysia. SAGE Open Medicine 2.

Hayden J. Health belief model. In: Hayden J (ed.) Introduction to health behavior theory. Sudbury, MA: Jones and Bartlett Publishers. 2009:31-34.

Gupta SK, Nayak RP, Vidyarthi SK. A study on the knowledge, attitude and practice of generic medicines among the doctors in a tertiary care teaching hospital in south India. Nat J Phyiol Pharm Pharmacol. 2015;5:39-44.